REGMEDNET.COM: Keyword Density Checker

Total words: 2002 | 2-word phrases: 495 | 3-word phrases: 577 | 4-word phrases: 617

PAGE INFO

Title	Try to keep the title under 60 characters (45 characters) The home of regenerative medicine - RegMedNet
Description	Try to keep the meta description between 50 - 160 characters (150 characters) Bringing you the latest news and views in regenerative medicine and cell therapy, in partnership with the journal Regenerative Medicine - all for free
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

ONE WORD PHRASES 313 Words

#	Keyword	Frequency	Density
1	2024	32	10.22%
2	in	31	9.90%
3	focus	21	6.71%
4	cell	21	6.71%
5	for	16	5.11%
6	jun	15	4.79%
7	therapy	15	4.79%
8	2023	14	4.47%
9	gene	13	4.15%
10	of	10	3.19%

TWO WORD PHRASES 495 Words

#	Keyword	Frequency	Density
1	in focus	17	3.43%
2	cell therapy	16	3.23%
3	jun 2024	15	3.03%
4	focus in	10	2.02%
5	2023 in	8	1.62%
6	gene therapy	8	1.62%
7	regenerative medicine	7	1.41%
8	oct 2023	6	1.21%
9	10 jun	6	1.21%
10	2024 gene	5	1.01%
11	2024 in	5	1.01%
12	feb 2024	5	1.01%
13	tissue engineering	5	1.01%
14	articleregenerative medicine	4	0.81%
15	research articleregenerative	4	0.81%
16	2024 research	4	0.81%
17	gene editing	4	0.81%
18	for cell	4	0.81%
19	on social	4	0.81%
20	social media	4	0.81%

THREE WORD PHRASES 577 Words

#	Keyword	Frequency	Density
1	focus in focus	9	1.56%
2	in focus in	7	1.21%
3	10 jun 2024	6	1.04%
4	2023 in focus	5	0.87%
5	jun 2024 gene	5	0.87%
6	research articleregenerative medicine	4	0.69%
7	us on social	4	0.69%
8	2024 research articleregenerative	4	0.69%
9	2024 cell therapy	4	0.69%
10	2024 gene therapy	4	0.69%
11	on social media	4	0.69%
12	follow us on	4	0.69%
13	scaffolds from stored	3	0.52%
14	approval for duchenne	3	0.52%
15	cell therapy weekly	3	0.52%
16	therapyarticle cell therapy	3	0.52%
17	for duchenne muscular	3	0.52%
18	duchenne muscular dystrophy	3	0.52%
19	27 jun 2024	3	0.52%
20	approach to derive	3	0.52%
21	to derive sheep	3	0.52%
22	derive sheep corneal	3	0.52%
23	sheep corneal scaffolds	3	0.52%
24	jun 2024 in	3	0.52%
25	corneal scaffolds from	3	0.52%
26	top 3 grants	2	0.35%
27	weekly fda grants	2	0.35%
28	an interview with	2	0.35%
29	2024 gene therapyarticle	2	0.35%
30	dystrophy gene therapy	2	0.35%

FOUR WORD PHRASES 617 Words

#	Keyword	Frequency	Density
1	in focus in focus	6	0.97%
2	2023 in focus in	5	0.81%
3	jun 2024 gene therapy	4	0.65%
4	2024 research articleregenerative medicine	4	0.65%
5	follow us on social	4	0.65%
6	us on social media	4	0.65%
7	corneal scaffolds from stored	3	0.49%
8	for duchenne muscular dystrophy	3	0.49%
9	27 jun 2024 gene	3	0.49%
10	10 jun 2024 in	3	0.49%
11	approach to derive sheep	3	0.49%
12	to derive sheep corneal	3	0.49%
13	approval for duchenne muscular	3	0.49%
14	sheep corneal scaffolds from	3	0.49%
15	derive sheep corneal scaffolds	3	0.49%
16	jun 2024 gene therapyarticle	2	0.32%
17	10 jun 2024 research	2	0.32%
18	jun 2024 research articleregenerative	2	0.32%
19	research articleregenerative medicine a	2	0.32%
20	glossary for advanced therapies	2	0.32%
21	oct 2023 in focus	2	0.32%
22	sustainable approach to derive	2	0.32%
23	therapyarticle cell therapy weekly	2	0.32%
24	gene therapyarticle cell therapy	2	0.32%
25	top 3 grants in	2	0.32%
26	lines and improved differentiation	2	0.32%
27	ipsc lines and improved	2	0.32%
28	cell therapy weekly fda	2	0.32%
29	duchenne muscular dystrophy gene	2	0.32%
30	jun 2024 interviewsarticle branching	2	0.32%
31	tissue engineering or replacements	2	0.32%
32	10 jun 2024 interviewsarticle	2	0.32%
33	peek behind the paper	2	0.32%
34	behind the paper a	2	0.32%
35	in focus angiogenesis 10	2	0.32%
36	muscular dystrophy gene therapy	2	0.32%
37	symposium new gmp ipsc	2	0.32%
38	further approval for duchenne	2	0.32%
39	grants further approval for	2	0.32%
40	focus in focus angiogenesis	2	0.32%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.futuremedicine.com/journal/rme	Whois	futuremedicine.com
2	https://www.facebook.com/regmednet/	Whois	facebook.com
3	https://twitter.com/RegMedNet	Whois	twitter.com
4	https://www.linkedin.com/company/regmednet	Whois	linkedin.com
5	https://www.future-science-group.com/wechat	Whois	future-science-group.com
6	https://www.facebook.com/regmednet/	Whois	facebook.com
7	https://twitter.com/RegMedNet	Whois	twitter.com
8	https://www.linkedin.com/company/regmednet	Whois	linkedin.com
9	https://www.future-science-group.com/wechat	Whois	future-science-group.com
10	https://www.facebook.com/regmednet/	Whois	facebook.com
11	https://twitter.com/RegMedNet	Whois	twitter.com
12	https://www.linkedin.com/company/regmednet	Whois	linkedin.com
13	https://www.future-science-group.com/wechat	Whois	future-science-group.com
14	https://www.facebook.com/regmednet/	Whois	facebook.com
15	https://twitter.com/RegMedNet	Whois	twitter.com
16	https://www.linkedin.com/company/regmednet	Whois	linkedin.com
17	https://www.future-science-group.com/wechat	Whois	future-science-group.com
18	https://www.facebook.com/regmednet/	Whois	facebook.com
19	https://twitter.com/RegMedNet	Whois	twitter.com
20	https://www.linkedin.com/company/regmednet	Whois	linkedin.com
21	https://www.future-science-group.com/wechat	Whois	future-science-group.com
22	https://taylorandfrancis.com/	Whois	taylorandfrancis.com
23	https://taylorandfrancis.com/	Whois	taylorandfrancis.com
24	https://www.informa.com/generic-content/cookie-policy/	Whois	informa.com
25	https://www.informa.com/privacy-policy/	Whois	informa.com
26	https://www.informa.com/generic-content/terms--conditions/	Whois	informa.com